The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Management of progressive brain metastases in patients (pts) with relapsed germ-cell tumor (GCT) treated with salvage high-dose chemotherapy (HDCT).
 
Jennifer King
No Relationships to Disclose
 
Rafat Abonour
Consulting or Advisory Role - BMS (Inst); Genentech; Janssen Oncology; Takeda
Speakers' Bureau - Johnson & Johnson/Janssen
Research Funding - Janssen (Inst)
 
Rebecca Hassoun
Research Funding - Natera (Inst)
 
Sandra K. Althouse
No Relationships to Disclose
 
Tareq Salous
No Relationships to Disclose
 
Nasser H. Hanna
Research Funding - Bristol-Myers Squibb (Inst); Genentech (Inst); Merck KGaA (Inst); Signatera (Inst)
 
Lawrence H. Einhorn
Stock and Other Ownership Interests - Amgen
 
Nabil Adra
Consulting or Advisory Role - Astellas Pharma; Aveo; Bristol Myers Squibb Foundation; Bristol Myers Squibb Foundation; EMD Serono; Exelixis; Merck; Sanofi
Research Funding - Exelixis (Inst); Genentech (Inst); Merck (Inst); Natera (Inst)